Characterization of a conformationally sensitive TOAC spin-labeled substance P

Peptides

Volumn 29, Issue 11, 2008, Pages 1919-1929

  Shafer, Aaron M ^a   Nakaie, Clovis R ^c   Deupi, Xavier ^d   Bennett, Vicki J ^b   Voss, John C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d Physiology Section   (Spain)

Author keywords

EPR; ESR; GPCR; Substance P; TOAC spin label

Indexed keywords

4 AMINO 4 CARBOXY 2,2,6,6 TETRAMETHYLPIPERIDINO 1 OXYL; AMINO ACID DERIVATIVE; NEUROKININ 1 RECEPTOR; NITROXIDE DERIVATIVE; PIPERIDINE DERIVATIVE; SUBSTANCE P; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION;

ANIMALS; CHO CELLS; COMPUTER SIMULATION; CRICETINAE; CRICETULUS; ELECTRON SPIN RESONANCE SPECTROSCOPY; RECEPTORS, NEUROKININ-1; SUBSTANCE P;

EID: 54049093927     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2008.08.002     Document Type: Article

References (58)

1. Almeida T.A., Rojo J., Nieto P.M., Pinto F.M., Hernandez M., Martin J.D., et al. Tachykinins and tachykinin receptors: structure and activity relationships. Curr Med Chem 11 (2004) 2045-2081
2. Barany G., and Merrifield R.B. The peptides: analysis, synthesis and biology (1979), Academic Press, New York
3. Barbosa S.R., Cilli E.M., Lamy-Freund M.T., Castrucci A.M.L., and Nakaie C.R. First synthesis of a fully active spin-labeled peptide hormone. FEBS Lett 446 (1999) 45-48
4. Bockaert J., and Pin J.P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J 18 (1999) 1723-1729
5. Borbat P.P., Costa-Filho A.J., Earle K.A., Moscicki J.K., and Freed J.H. Electron spin resonance in studies of membranes and proteins. Science 291 (2001) 266-269
6. Bremer A.A., Leeman S.E., and Boyd N.D. Evidence for spatial proximity of two distinct receptor regions in the substance P (SP)*neurokinin-1 receptor (NK-1R) complex obtained by photolabeling the NK-1R with p-benzoylphenylalanine3-SP. J Biol Chem 276 (2001) 22857-22861
7. Carlotto S., Cimino P., Zerbetto M., Franco L., Corvaja C., Crisma M., et al. Unraveling solvent-driven equilibria between alpha- and 3(10)-helices through an integrated spin labeling and computational approach. J Am Chem Soc 129 (2007) 11248-11258
8. Cascieri M.A., Ber E., Fong T.M., Sadowski S., Bansal A., Swain C., et al. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor. Mol Pharmacol 42 (1992) 458-463
9. Cascieri M.A., Huang R.R., Fong T.M., Cheung A.H., Sadowski S., Ber E., et al. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors. Mol Pharmacol 41 (1992) 1096-1099
10. Chassaing G., Convert O., and Lavielle S. Preferential conformation of substance P in solution. Eur J Biochem 154 (1986) 77-85
11. Darden T.A., and Pedersen L.G. Molecular modeling: an experimental tool. Environ Health Perspect 101 (1993) 410-412
12. Datar P., Srivastava S., Coutinho E., and Govil G. Substance P: structure, function, and therapeutics. Curr Top Med Chem 4 (2004) 75-103
13. De Lean A., Stadel J.M., and Lefkowitz R.J. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. J Biol Chem 255 (1980) 7108-7117
14. Deupi X., and Kobilka B. Activation of G protein-coupled receptors. Adv Protein Chem 74 (2007) 137-166
15. Duan Y., Wu C., Chowdhury S., Lee M.C., Xiong G., Zhang W., et al. A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem 24 (2003) 1999-2012
16. Elling C.E., Raffetseder U., Nielsen S.M., and Schwartz T.W. Disulfide bridge engineering in the tachykinin NK1 receptor. Biochemistry 39 (2000) 667-675
17. Fernandez R.M., Vieira R.F., Nakaie C.R., Ito A.S., and Lamy M.T. Peptide-lipid interaction monitored by spin labeled biologically active melanocortin peptides. Peptides 26 (2005) 1825-1834
18. Fields G.B., and Noble R.L. Solid phase peptide synthesis utilizing 9-fluorenylmethoxycarbonyl amino acids. Int J Pept Protein Res 35 (1990) 161-214
19. Flippen-Anderson J.L., George C., Valle G., Valente E., Bianco A., Formaggio F., et al. Crystallographic characterization of geometry and conformation of TOAC, a nitroxide spin-labelled C alpha,alpha-disubstituted glycine, in simple derivatives and model peptides. Int J Pept Protein Res 47 (1996) 231-238
20. Gether U., Asmar F., Meinild A.K., and Rasmussen S.G. Structural basis for activation of G-protein-coupled receptors. Pharmacol Toxicol 91 (2002) 304-312
21. Ghanouni P., Steenhuis J.J., Farrens D.L., and Kobilka B.K. Agonist-induced conformational changes in the G-protein-coupling domain of the beta 2 adrenergic receptor. PNAS 98 (2001) 5997-6002
22. Hastrup H., and Schwartz T.W. Septide and neurokinin A are high-affinity ligands on the NK-1 receptor: evidence from homologous versus heterologous binding analysis. FEBS Lett 399 (1996) 264-266
23. Hyde J.S. Trends in EPR technology. In: Eaton S.S., Eaton G.R., and Berliner L.J. (Eds). Biological magnetic resonance: biomedical EPR-Part B: Methodology and instrumentation (2005), Kluwer Academic Publishers, Boston 409-426
24. Improta R., and Barone V. Interplay of electronic, environmental, and vibrational effects in determining the hyperfine coupling constants of organic free radicals. Chem Rev 104 (2004) 1231-1254
25. Kenakin T. Principles: receptor theory in pharmacology. Trends Pharmacol Sci 25 (2004) 186-192
26. Kobilka B.K., and Deupi X. Conformational complexity of G-protein-coupled receptors. Trends Pharmacol Sci 28 (2007) 397-406
27. Kumar S., and Bansal M. Dissecting alpha-helices: position-specific analysis of alpha-helices in globular proteins. Proteins 31 (1998) 460-476
28. Lavielle S., Chassaing G., Ploux O., Loeuillet D., Besseyre J., Julien S., et al. Analysis of tachykinin binding site interactions using constrained analogues of tachykinins. Biochem Pharmacol 37 (1988) 41-49
29. Li H., Leeman S.E., Slack B.E., Hauser G., Saltsman W.S., Krause J.E., et al. A substance P (neurokinin-1) receptor mutant carboxyl-terminally truncated to resemble a naturally occurring receptor isoform displays enhanced responsiveness and resistance to desensitization. Proc Natl Acad Sci USA 94 (1997) 9475-9480
30. Maggi C.A. The mammalian tachykinin receptors. Gen Pharmacol 26 (1995) 911-944
31. Maggi C.A., and Schwartz T.W. The dual nature of the tachykinin NK-1 receptor. Trends Pharmacol Sci 18 (1997) 351-355
32. Marchetto R., Schreier S., and Nakaie C.R. A novel spin-labeled amino acid derivative for use in peptide synthesis: (9-fluorenylmethyloxycarbonyl)-2,2,6, 6-tetramethylpiperidine-N-oxyl-4-amino-4-carboxylic acid. J Am Chem Soc 115 (1993) 11042-11043
33. McNulty J.C., and Millhauser G.L. The rigid nitroxide side chain. In: Berliner (Ed). Biological magnetic resonance, distance measurement in biological systems by EPR vol. 19 (2000), Kluwer Academic/Plenum Publishers, New York 277-305
34. Nakaie C.R., Barbosa S.R., Vieira R.F.F., Fernandez R.M., Cilli E.M., Castrucci A.M.L., et al. Comparative EPR and fluorescence conformational studies of fully active spin-labeled melanotropic peptides. FEBS Lett 497 (2001) 103-107
35. Nakaie C.R., Silva E.G., Cilli E.M., Marchetto R., Schreier S., Paiva T.B., et al. Synthesis and pharmacological properties of TOAC-labeled angiotensin and bradykinin analogs. Peptides 23 (2002) 65-70
36. Neubig R.R., and Sklar L.A. Subsecond modulation of formyl peptide-linked guanine nucleotide-binding proteins by guanosine 5′-O-(3-thio)triphosphate in permeabilized neutrophils. Mol Pharmacol 43 (1993) 734-740
37. Palanche T., Ilien B., Zoffmann S., Reck M.P., Bucher B., Edelstein S.J., et al. The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states. J Biol Chem 276 (2001) 34853-34861
38. Pellegrini M., Bremer A.A., Ulfers A.L., Boyd N.D., and Mierke D.F. Molecular characterization of the substance P*neurokinin-1 receptor complex: development of an experimentally based model. J Biol Chem 276 (2001) 22862-22867
39. Pennefather J.N., Lecci A., Candenas M.L., Patak E., Pinto F.M., and Maggi C.A. Tachykinins and tachykinin receptors: a growing family. Life Sci 74 (2004) 1445-1463
40. Ploux O., Lavielle S., Chassaing G., Julien S., Marquet A., d'Orleans-Juste P., et al. Interaction of tachykinins with their receptors studied with cyclic analogues of substance P and neurokinin B. Proc Natl Acad Sci USA 84 (1987) 8095-8099
41. 2 of substance P using [3-prolinoleucine10]SP analogues. Eur J Biochem 270 (2003) 2869-2878
42. Raddatz R., Crankshaw C.L., Snider R.M., and Krause J.E. Similar rates of phosphatidylinositol hydrolysis following activation of wild-type and truncated rat neurokinin-1 receptors. J Neurochem 64 (1995) 1183-1191
43. Sagan S., Chassaing G., Pradier L., and Lavielle S. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J Pharmacol Exp Therap 276 (1996) 1039-1048
44. 2 tripeptide of substance P bound to the NK-1 receptor. Chem Biol 12 (2005) 555-565
45. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234 (1993) 779-815
46. Schreier S., Barbosa S.R., Casallanovo F., Vieira Rde F., Cilli E.M., Paiva A.C., et al. Conformational basis for the biological activity of TOAC-labeled angiotensin II and bradykinin: electron paramagnetic resonance, circular dichroism, and fluorescence studies. Biopolymers 74 (2004) 389-402
47. Severini C., Improta G., Falconieri-Erspamer G., Salvadori S., and Erspamer V. The tachykinin peptide family. Pharmacol Rev 54 (2002) 285-322
48. Shafer A., and Voss J. The use of spin-labeled ligands as biophysical probes to report real-time endocytosis of G protein-coupled receptors in living cells. Sci STKE 2004 (2004) l9
49. Shafer A.M., Bennett V.J., Kim P., and Voss J.C. Probing the binding pocket and endocytosis of a G protein-coupled receptor in live cells reported by a spin-labeled substance P agonist. J Biol Chem 278 (2003) 34203-34210
50. Swaminath G., Deupi X., Lee T.W., Zhu W., Thian F.S., Kobilka T.S., et al. Probing the beta2 adrenoceptor binding site with catechol reveals differences in binding and activation by agonists and partial agonists. J Biol Chem 280 (2005) 22165-22171
51. Swaminath G., Xiang Y., Lee T.W., Steenhuis J., Parnot C., and Kobilka B.K. Sequential binding of agonists to the beta2 adrenoceptor, Kinetic evidence for intermediate conformational states. J Biol Chem 279 (2004) 686-691
52. Toniolo C., Crisma M., and Formaggio F. TOAC, a nitroxide spin-labeled, achiral Calpha-tetrasubstituted alpha-amino acid, is an excellent tool in material science and biochemistry. Biopolymers 47 (1998) 153-158
53. Tota M.R., Daniel S., Sirotina A., Mazina K.E., Fong T.M., Longmore J., et al. Characterization of a fluorescent substance P analog. Biochemistry 33 (1994) 13079-13086
54. Turcatti G., Nemeth K., Edgerton M.D., Knowles J., Vogel H., and Chollet A. Fluorescent labeling of NK2 receptor at specific sites in vivo and fluorescence energy transfer analysis of NK2 ligand-receptor complexes. Receptors Channels 5 (1997) 201-207
55. Turcatti G., Nemeth K., Edgerton M.D., Meseth U., Talabot F., Peitsch M., et al. Probing the structure and function of the tachykinin neurokinin-2 receptor through biosynthetic incorporation of fluorescent amino acids at specific sites. J Biol Chem 271 (1996) 19991-19998
56. Turcatti G., Zoffmann S., Lowe J.A., Drozda S.E., Chassaing G., Schwartz T.W., et al. Characterization of non-peptide antagonist and peptide agonist binding sites of the NK1 receptor with fluorescent ligands. J Biol Chem 272 (1997) 21167-21175
57. Wijkhuisen A., Sagot M.-A., Frobert Y., Creminon C., Grassi J., Boquet D., et al. Identification in the NK1 tachykinin receptor of a domain involved in recognition of neurokinin A and septide but not of substance P. FEBS Lett 447 (1999) 155-159
58. Yao X., Parnot C., Deupi X., Ratnala V.R., Swaminath G., Farrens D., et al. Coupling ligand structure to specific conformational switches in the beta2-adrenoceptor. Nat Chem Biol 2 (2006) 417-422